Edwards Lifesciences Corp (NYSE:EW)
$ 88.96 -1.15 (-1.28%) Market Cap: 53.61 Bil Enterprise Value: 53.30 Bil PE Ratio: 38.34 PB Ratio: 7.53 GF Score: 98/100

Edwards Lifesciences Corp at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 09, 2020 / 07:50PM GMT
Release Date Price: $74.96 (-2.59%)
Amit Hazan
Goldman Sachs Group, Inc., Research Division - Equity Analyst

Okay. Good afternoon. We're back here. I'm Amit Hazan, the Goldman Sachs medtech analyst. And late afternoon session here, we have Edwards Lifesciences with us. We've got Scott Ullem, the Chief Financial Officer, here with us today. So first and foremost, Scott, busy time for everyone, so I just wanted to thank you for making it out to the conference virtually, and appreciate your time.

Scott B. Ullem
Edwards Lifesciences Corporation - Corporate VP & CFO

Yes, for sure. No, it's great to be here. Good to see you, Amit.

Questions & Answers

Amit Hazan;
Goldman Sachs Group, Inc., Research Division - Equity Analyst

You too. And I thought, just given the news last night, maybe it's better, just right at the top, to give you a chance to frame the China approval in the right way. Just maybe talk through how that opportunity ramps from here, both in terms of opportunity and limitations to how -- what needs to happen.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot